Bonesupport Holding stock
Price history
+63.87% over the period1 year: from kr 198.20 (November 20, 2025) to kr 324.80 (November 20, 2026), +63.87%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | kr 324.80 |
| October 30, 2026 | kr 325.00 |
| September 30, 2026 | kr 227.60 |
| August 31, 2026 | kr 218.60 |
| July 31, 2026 | kr 220.20 |
| June 30, 2026 | kr 211.40 |
| May 29, 2026 | kr 229.80 |
| April 30, 2026 | kr 220.60 |
| March 31, 2026 | kr 194.90 |
| February 27, 2026 | kr 202.40 |
| January 30, 2026 | kr 185.00 |
| December 30, 2025 | kr 188.00 |
| November 28, 2025 | kr 201.80 |
| November 20, 2025 | kr 198.20 |
At a glance
The company
Develops and commercializes injectable bio-ceramic bone graft substitutes for bone repair and infection prevention
Latest results
Quarter to September 30, 2026 · EPS kr 1.40 (estimate kr 1.26)
TickerLandia's take on Bonesupport Holding
- Pricier than similar companies: trailing 12-month P/E 78 vs 25 (+211%) in a group of 9.
- Strong point: Market momentum (97/100 in its group). Weak point: Earnings stability (4/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−4.53% from the 52-week high
Analysts · 5 analysts
Average targetkr 374.67+15.35% vs. price
Buy 5 · Hold 0 · Sell 0
TickerLandia Fingerprint: Bonesupport Holding
Compared with similar companies: very strong momentum, very low earnings stability, and very high growth.
Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricevery high95
How much it costs relative to what it produces.
Metric Value Position in group Forward P/E 72.9 96 P/E (trailing 12 months) 78.1 88 Price/book 20.9 99 Price/sales 14.8 99 EV/EBITDA 56.5 93 Profitabilityvery high90
How much it earns on revenue and capital.
Metric Value Position in group ROE 29.7% 96 Gross margin 91.9% 99 Operating margin 25.5% 78 Net margin 19.4% 81 ROA 20.6% 99 Earnings stabilityvery low4
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 26.2% 1 Loss-making yearscounts in reverse: lower means more earnings stability 2 of 5 annual reports 7 Growthvery high95
How fast revenue and earnings are growing.
Metric Value Position in group Revenue growth (year over year) +39.00% 99 Earnings growth (year over year) +167.30% 88 Average revenue growth (3 years) +52.87% 99 Financial strengthvery high85
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 7.04 52 Current ratio 5.73 96 Debt/equitycounts in reverse: lower means more financial strength 0.01 98 Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −1.31 95 Dividendno dividend
How much it returns to shareholders, and for how long.
Market momentumvery strong97
How the stock has moved compared with the market.
Metric Value Position in group 1-year return +63.87% 95 Distance from 200-day average +41.08% 99 Riskhigh75
How much the price swings.
Metric Value Position in group Volatility (60 days) 57.8% 95 Maximum drawdown (12 months) 25.9% 55
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Bonesupport Holding is pricier than similar companies
Bonesupport Holding's P/E (trailing 12 months): 78.1, +211% against the median of a group of 9 similar companies (25.1).
Compared with 9 similar companies
| Metric | Bonesupport Holding | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 78.1 | High | |
| Forward P/E | 72.9 | High | |
| Operating margin | 25.5% | High | |
| ROE | 29.7% | High | |
| Debt/equity | 0.01 | Low |
Grey band: the middle half of the group; tick: the median; dot: Bonesupport Holding. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
kr 408.83M
Latest quarter · Q3 2026
Net income
kr 92.36M
Latest quarter · Q3 2026
Quarterly net margin
22.6%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- kr 20.72B
- P/E
- 78.1
- EPS
- kr 4.08
- Volume
- 183.24K
- Daily trading
- €9.14M
- Dividend yield
- 0.00%
How Bonesupport Holding is changing
All resultsRevenue grew 45.4% a year on average over the last 5 years
Operating margin rose from −20.6% to 23.6%
Less cash than profit: free cash flow equal to 51% of net income
Returns
Bonesupport Holding returns
kr 1,000 invested in Bonesupport Holding 5 years ago, on November 22, 2021, would be worth kr 8,458 today: +745.83% in total, +53.35% per year. This is the price return only: dividends are excluded.
| Period | Bonesupport Holding | kr 1,000 becomes |
|---|---|---|
| 1 month | +27.87% | kr 1,279 |
| 6 months | +25.60% | kr 1,256 |
| Year to date | +72.77% | kr 1,728 |
| 1 year | +63.87% | kr 1,639 |
| 3 years | +98.05% | kr 1,980 |
| 5 years | +745.83% | kr 8,458 |
Price only, without dividends. Calculate your investment
The chart in detail
Bonesupport Holding: technical analysis
Bonesupport Holding is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 18.8% below its all-time closing high (kr 400.20, January 3, 2025).
- Trend
- Upward
- RSI (14 sessions)
- 63
- Between 30 and 70
- vs 200-session average
- +41.08%
Active signals
The price is moving in an unusually narrow range compared with the last year.
Support and resistance
Price areas where Bonesupport Holding has stopped several times in the last year. They describe the chart; they are not forecasts.
- No resistance above: the price is near the highs of the year
- Last pricekr 324.80
- Supportkr 245.40−24.45%2 touches, last on October 21, 2026
- Supportkr 234.37−27.84%7 touches, last on September 30, 2026
- Supportkr 215.30−33.71%4 touches, last on October 8, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 57.8%
- Largest fall in the last year
- −25.95%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Bonesupport Holding: seasonality
Average monthly price change over 10 years
Over the last 10 years, the strongest month for Bonesupport Holding has been July: +10.28% on average, positive in 9 years out of 10. The weakest has been March: −3.96% on average, positive in 4 years out of 9. November, the current month, has been positive in 5 years out of 9 (+3.66% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | −0.32% | −3.59% | 3 of 9 |
| February | −0.91% | +0.83% | 5 of 9 |
| March | −3.96% | −3.71% | 4 of 9 |
| April | +7.53% | +9.67% | 6 of 9 |
| May | +7.18% | +7.35% | 7 of 9 |
| June | +7.95% | +8.04% | 7 of 9 |
| July | +10.28% | +9.76% | 9 of 10 |
| August | −2.37% | −0.79% | 4 of 10 |
| September | +4.96% | +1.65% | 6 of 10 |
| October | +3.08% | +1.19% | 5 of 10 |
| November | +3.66% | +1.34% | 5 of 9 |
| December | +3.06% | +5.57% | 5 of 9 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Bonesupport Holding and its competitors
CERAMENT is the name customers know Bonesupport by: an injectable bio-ceramic bone graft substitute that remodels into host bone. The range includes CERAMENT G and CERAMENT V, which elute gentamicin or vancomycin during the first 30 days of bone healing and are used to treat and prevent bone infection, and CERAMENT Bead Tray, a local delivery option for surgeons treating osseous defects and dead space. The company sells these orthobiologics products in the United States, Europe and other international markets.
- Headquarters
- Lund, Sweden
- Employees
- 174
- Founded
- 1999
- Chief executive
- Torbjorn Skold
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Bonesupport HoldingBONEX | $2.03B | 25.5% | 78.1 | +25.60% |
| AddLifeALIF.B | $2.11B | 8.9% | 33.5 | +17.73% |
| OttobockOBCK | $2.68B | 18.7% | 19.0 | −31.33% |
| Carl Zeiss MeditecAFX | $3.07B | 7.2% | 23.3 | +24.32% |
| GerresheimerGXI | $1.19B | 1.6% | — | +21.95% |
| Tecan GroupTECN | $3.58B | 4.9% | — | +64.44% |
Same industry or related industries, similar size. Compare Bonesupport Holding with its competitors · Full profile
